Order Article Reprints

Barr MP, Baird A-M, Halliday S, Martin P, Allott EH, Phelan J, Korpanty G, Coate L, O’Brien C, Gray SG, et al. Liquid Biopsy: A Multi-Parametric Analysis of Mutation Status, Circulating Tumor Cells and Inflammatory Markers in EGFR-Mutated NSCLC. Diagnostics. 2022; 12(10):2360. https://doi.org/10.3390/diagnostics12102360

Barr, Martin P., Anne-Marie Baird, Sophia Halliday, Petra Martin, Emma H. Allott, James Phelan, Greg Korpanty, Linda Coate, Cathal O’Brien, Steven G. Gray, and et al. 2022. "Liquid Biopsy: A Multi-Parametric Analysis of Mutation Status, Circulating Tumor Cells and Inflammatory Markers in EGFR-Mutated NSCLC" Diagnostics 12, no. 10: 2360. https://doi.org/10.3390/diagnostics12102360

Barr, M. P., Baird, A.-M., Halliday, S., Martin, P., Allott, E. H., Phelan, J., Korpanty, G., Coate, L., O’Brien, C., Gray, S. G., Sui, J. S. Y., Hayes, B., Cuffe, S., & Finn, S. P. (2022). Liquid Biopsy: A Multi-Parametric Analysis of Mutation Status, Circulating Tumor Cells and Inflammatory Markers in EGFR-Mutated NSCLC. Diagnostics, 12(10), 2360. https://doi.org/10.3390/diagnostics12102360